0078-0713 : Jadenu 180 mg Oral Granule
| NDC: | 0078-0713 |
| Labeler: | Novartis Pharmaceuticals Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Jadenu |
| Dosage Form: | Oral Granule |
| Application #: | NDA207968 |
| Rev. Date: |
NDC Package Codes:
- 0078-0713-15: 30 PACKET IN 1 CARTON (0078‑0713‑15) > 1 GRANULE IN 1 PACKET (0078‑0713‑19)
Active Ingredients:
- Deferasirox
Dosage Strength:
- 180 mg
Pharmaceutical Classes:
- Cytochrome P450 1A2 Inhibitors [MoA]
- Cytochrome P450 2C8 Inhibitors [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- Iron Chelating Activity [MoA]
- Iron Chelator [EPC]
Related Products:
Based on records with the same trade name.- 0078-0654 Jadenu 90 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0655 Jadenu 180 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0656 Jadenu 360 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0720 Jadenu 360 mg Oral Granule by Novartis Pharmaceuticals Corporation
- 0078-0727 Jadenu 90 mg Oral Granule by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0078-0709Next: 0078-0715 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.